This course is designed for cell biologists, research scientists, process engineers, trainees (and other end users) who want to have a basic understanding of what cell and gene therapy manufacturing under GMP means.
At the end of this course, the participants will be able to:
- Explain how production under GMP differs from routine laboratory work, including process development;
- Identify the main components of Quality Management Systems (QMS) required to manufacture biotherapeutics under GMP;
- Describe the critical path and steps to translate process development into GMP production: minimizing risk.
Completing this course will take you less than 60 minutes and will provide you with a certificate of completion after passing the exam.